Cargando…

Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland

BACKGROUND: In Finland, the first infections caused by the 2009 pandemic influenza A(H1N1) virus were identified on May 10. During the next three months almost all infections were found from patients who had recently traveled abroad. In September 2009 the pandemic virus started to spread in the gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikonen, Niina, Haanpää, Minna, Rönkkö, Esa, Lyytikäinen, Outi, Kuusi, Markku, Ruutu, Petri, Kallio-Kokko, Hannimari, Mannonen, Laura, Lappalainen, Maija, Ziegler, Thedi, Julkunen, Ilkka
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958116/
https://www.ncbi.nlm.nih.gov/pubmed/20975994
http://dx.doi.org/10.1371/journal.pone.0013329
_version_ 1782188299137318912
author Ikonen, Niina
Haanpää, Minna
Rönkkö, Esa
Lyytikäinen, Outi
Kuusi, Markku
Ruutu, Petri
Kallio-Kokko, Hannimari
Mannonen, Laura
Lappalainen, Maija
Ziegler, Thedi
Julkunen, Ilkka
author_facet Ikonen, Niina
Haanpää, Minna
Rönkkö, Esa
Lyytikäinen, Outi
Kuusi, Markku
Ruutu, Petri
Kallio-Kokko, Hannimari
Mannonen, Laura
Lappalainen, Maija
Ziegler, Thedi
Julkunen, Ilkka
author_sort Ikonen, Niina
collection PubMed
description BACKGROUND: In Finland, the first infections caused by the 2009 pandemic influenza A(H1N1) virus were identified on May 10. During the next three months almost all infections were found from patients who had recently traveled abroad. In September 2009 the pandemic virus started to spread in the general population, leading to localized outbreaks and peak epidemic activity was reached during weeks 43–48. METHODS/RESULTS: The nucleotide sequences of the hemagglutinin (HA) and neuraminidase (NA) genes from viruses collected from 138 patients were determined. The analyzed viruses represented mild and severe infections and different geographic regions and time periods. Based on HA and NA gene sequences, the Finnish pandemic viruses clustered in four groups. Finnish epidemic viruses and A/California/07/2009 vaccine virus strain varied from 2–8 and 0–5 amino acids in HA and NA molecules, respectively, giving a respective maximal evolution speed of 1.4% and 1.1%. Most amino acid changes in HA and NA molecules accumulated on the surface of the molecule and were partly located in antigenic sites. Three severe infections were detected with a mutation at HA residue 222, in two viruses with a change D222G, and in one virus D222Y. Also viruses with change D222E were identified. All Finnish pandemic viruses were sensitive to oseltamivir having the amino acid histidine at residue 275 of the neuraminidase molecule. CONCLUSIONS: The Finnish pandemic viruses were quite closely related to A/California/07/2009 vaccine virus. Neither in the HA nor in the NA were changes identified that may lead to the selection of a virus with increased epidemic potential or exceptionally high virulence. Continued laboratory-based surveillance of the 2009 pandemic influenza A(H1N1) is important in order to rapidly identify drug resistant viruses and/or virus variants with potential ability to cause severe forms of infection and an ability to circumvent vaccine-induced immunity.
format Text
id pubmed-2958116
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-29581162010-10-25 Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland Ikonen, Niina Haanpää, Minna Rönkkö, Esa Lyytikäinen, Outi Kuusi, Markku Ruutu, Petri Kallio-Kokko, Hannimari Mannonen, Laura Lappalainen, Maija Ziegler, Thedi Julkunen, Ilkka PLoS One Research Article BACKGROUND: In Finland, the first infections caused by the 2009 pandemic influenza A(H1N1) virus were identified on May 10. During the next three months almost all infections were found from patients who had recently traveled abroad. In September 2009 the pandemic virus started to spread in the general population, leading to localized outbreaks and peak epidemic activity was reached during weeks 43–48. METHODS/RESULTS: The nucleotide sequences of the hemagglutinin (HA) and neuraminidase (NA) genes from viruses collected from 138 patients were determined. The analyzed viruses represented mild and severe infections and different geographic regions and time periods. Based on HA and NA gene sequences, the Finnish pandemic viruses clustered in four groups. Finnish epidemic viruses and A/California/07/2009 vaccine virus strain varied from 2–8 and 0–5 amino acids in HA and NA molecules, respectively, giving a respective maximal evolution speed of 1.4% and 1.1%. Most amino acid changes in HA and NA molecules accumulated on the surface of the molecule and were partly located in antigenic sites. Three severe infections were detected with a mutation at HA residue 222, in two viruses with a change D222G, and in one virus D222Y. Also viruses with change D222E were identified. All Finnish pandemic viruses were sensitive to oseltamivir having the amino acid histidine at residue 275 of the neuraminidase molecule. CONCLUSIONS: The Finnish pandemic viruses were quite closely related to A/California/07/2009 vaccine virus. Neither in the HA nor in the NA were changes identified that may lead to the selection of a virus with increased epidemic potential or exceptionally high virulence. Continued laboratory-based surveillance of the 2009 pandemic influenza A(H1N1) is important in order to rapidly identify drug resistant viruses and/or virus variants with potential ability to cause severe forms of infection and an ability to circumvent vaccine-induced immunity. Public Library of Science 2010-10-20 /pmc/articles/PMC2958116/ /pubmed/20975994 http://dx.doi.org/10.1371/journal.pone.0013329 Text en Ikonen et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ikonen, Niina
Haanpää, Minna
Rönkkö, Esa
Lyytikäinen, Outi
Kuusi, Markku
Ruutu, Petri
Kallio-Kokko, Hannimari
Mannonen, Laura
Lappalainen, Maija
Ziegler, Thedi
Julkunen, Ilkka
Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland
title Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland
title_full Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland
title_fullStr Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland
title_full_unstemmed Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland
title_short Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland
title_sort genetic diversity of the 2009 pandemic influenza a(h1n1) viruses in finland
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958116/
https://www.ncbi.nlm.nih.gov/pubmed/20975994
http://dx.doi.org/10.1371/journal.pone.0013329
work_keys_str_mv AT ikonenniina geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT haanpaaminna geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT ronkkoesa geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT lyytikainenouti geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT kuusimarkku geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT ruutupetri geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT kalliokokkohannimari geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT mannonenlaura geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT lappalainenmaija geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT zieglerthedi geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland
AT julkunenilkka geneticdiversityofthe2009pandemicinfluenzaah1n1virusesinfinland